Preliminary clinical experience with cis-diamminedichloroplatinum (II) (NSC 119875, CACP)

Cancer. 1972 Dec;30(6):1451-6. doi: 10.1002/1097-0142(197212)30:6<1451::aid-cncr2820300606>3.0.co;2-q.
No abstract available

MeSH terms

  • Amines / adverse effects
  • Amines / therapeutic use*
  • Anemia / chemically induced
  • Antineoplastic Agents / administration & dosage
  • Antineoplastic Agents / adverse effects
  • Antineoplastic Agents / therapeutic use*
  • Audiometry
  • Blood Urea Nitrogen
  • Bone Marrow / drug effects
  • Bone Marrow Cells
  • Chlorides / adverse effects
  • Chlorides / therapeutic use
  • Dose-Response Relationship, Drug
  • Hearing Disorders / chemically induced
  • Humans
  • Kidney / drug effects
  • Leukopenia / chemically induced
  • Neoplasm Metastasis
  • Neoplasms / drug therapy*
  • Platinum / adverse effects
  • Platinum / therapeutic use*
  • Platinum / toxicity
  • Thrombocytopenia / chemically induced
  • Time Factors
  • Uric Acid / blood
  • Vomiting / chemically induced

Substances

  • Amines
  • Antineoplastic Agents
  • Chlorides
  • Uric Acid
  • Platinum